The Oral Iron Chelator Deferiprone Protects against Iron Overload–Induced Retinal Degeneration-Reference-Cited by-同舟云学术

The Oral Iron Chelator Deferiprone Protects against Iron Overload–Induced Retinal Degeneration

Published:2011-02-16 Issue:2 Volume:52 Page:959
ISSN:1552-5783
Container-title:Investigative Opthalmology & Visual Science
language:en
Short-container-title:Invest. Ophthalmol. Vis. Sci.

Author:

Hadziahmetovic Majda¹,Song Ying¹,Wolkow Natalie¹,Iacovelli Jared¹,Grieco Steven¹,Lee Jennifer¹,Lyubarsky Arkady¹,Pratico Domenico²,Connelly John³,Spino Michael³,Harris Z. Leah⁴,Dunaief Joshua L.¹

Affiliation:

1. From the F. M. Kirby Center for Molecular Ophthalmology, Scheie Eye Institute, University of Pennsylvania, Philadelphia, Pennsylvania;

2. the Department of Pharmacology, Temple University, Philadelphia, Pennsylvania;

3. ApoPharma, Inc., Toronto, Ontario, Canada; and

4. the Department of Pediatrics, Vanderbilt University, Nashville, Tennessee.

Publisher

Association for Research in Vision and Ophthalmology (ARVO)

Subject

General Medicine

Cited by 100 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Iron Chelator Deferiprone Restores Iron Homeostasis and Inhibits Retinal Neovascularization in Experimental Neovascular Age-Related Macular Degeneration;Investigative Ophthalmology & Visual Science;2024-08-02

2. Deferiprone promoted remyelination and functional recovery through enhancement of oligodendrogenesis in experimental demyelination animal model;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-07-24

3. Retinal toxicity of heavy metals and its involvement in retinal pathology;Food and Chemical Toxicology;2024-06

4. Both hemoglobin and hemin cause damage to retinal pigment epithelium through the iron ion accumulation;Journal of Pharmacological Sciences;2024-06

5. Ferroptosis as a potential therapeutic target for age-related macular degeneration;Drug Discovery Today;2024-04